1. A.F. Welton, W.C. Hope, M. O'Donnell, H. Baruth, H.J. Crowley, D.A. Miller, andB. Yaremko,Ro 22-3747: A New Antiallergic Agent for the Treatment of Immediate Hypersensitivity Diseases, J. Pharmac. Exp. Ther.228, 57–64 (1984).
2. A.W. Dunton, J.T. Connell, M. Scheinbaum, J.L. Data andB. McGhee,A Novel Decongestant Effect of Oral Ro 23-3747, A Mediator Release Inhibitor, In Patients With Allergic Rhinitis, American Society for Clinical Pharmacology and Therapeutics (in press).
3. S.P. Haydu, J.L. Bradley andD.T.D. Hughes,Inhibitory Effect of Oral Doxantrazole on Asthma Induced by Allergic Challenge, Br. Med. J.2, 283–284 (1975).
4. H.G. Johnson,New Antiallergy Drugs — The Lodoxamides, Trends in Pharmacological Science, pp. 343–345 (August, 1980).
5. R.L. Case, P.B. Rogers, P.P. VanArsdel andL.C. Altman,The Protective Effect of Lodoxamide on Antigen-Induced Bronchospasms, J. Am. Med. Ass.247, 661–664 (1982).